MatthewARankMD

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Consultant and Associate Professor of Medicine and Otolaryngology, Mayo Clinic Arizona, Co-director Multidisciplinary Clinic for Challenging Sinus Disease, Mayo Clinic Arizona, Co-director Severe Asthma Clinic, Phoenix Children's Hospital, Program Director, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery Scholars Program

Join to view full profile

Dr. Rank is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rank's full profile

Already have an account?

Office
13400 E Shea Blvd
Scottsdale, AZ 85259
Phone+1 480-301-8000

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Allergy and Immunology, 2006 - 2008
Ohio State University HospitalResidency, Internal Medicine/Pediatrics, 2002 - 2006
University of Wisconsin School of Medicine & Public HealthClass of 2002

Certifications & Licensure

AZ State Medical License 2012 - 2026
MN State Medical License 2006 - 2014
OH State Medical License 2002 - 2008
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Safe Administration of Flu Vaccine to Egg Allergic Children Start of enrollment: 2010 Oct 01
Completed
Not Applicable
Minimally Invasive Biomarker for Asthma Disease Severity Start of enrollment: 2014 Jul 01
Completed
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study Start of enrollment: 2019 Dec 19
Recruiting
Phase 2
Soluble Corn Fiber Supplementation for Asthma Start of enrollment: 2019 Sep 01
Completed
Phase 2
Roles: Contact
A Clinical Trial of Soluble Fiber for Asthma Start of enrollment: 2024 Apr 02
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis.
Grace C Pyon, Mia Y Masuda, Arina Putikova, Huijun Luo, Jessica B Gibson
The Journal of Allergy and Clinical Immunology. 2024-12-01
The Immediate and Delayed Maximal Nonirritating Skin Testing Concentrations of β-Lactam Antibiotics.
Alexei Gonzalez-Estrada, Ismael Carrillo-Martin, W Tatiana Garzon-Siatoya, Hajara Joundi, Dan Morgenstern-Kaplan
The Journal of Allergy and Clinical Immunology. in Practice. 2024-11-01
Incidence of and risk factors for paediatric perioperative anaphylaxis in the USA.
Ifat Z Krase, Christine R F Rukasin, Keith Sacco, Matthew A Rank, Gerald W Volcheck
British Journal of Anaesthesia. 2024-09-01

Press Mentions

Big Data Helps in Understanding Asthma Biologic Use, OutcomesJanuary 6th, 2022
From Basic to Translational Research: Scientist Uses Microbial Sequencing to Understand and Treat Respiratory DiseasesMarch 27th, 2018
Asthma Med Step down Can Be Safe, CostEffectiveOctober 27th, 2015
Join now to see all